In addition, meta-analysis of the relationship between ESR2 polymorphisms and BC susceptibility showed that the polymorphism rs4986938 was associated with reduced BC risk in overall population under both dominant and heterozygous models [6]. This evidence concerns the gene ESR2 and breast cancer.